Black Diamond Therapeutics (Nasdaq: BDTX) will present at the 46th Annual TD Cowen Healthcare Conference at 1:10 p.m. ET on March 4, 2026; the 25th Annual Needham Virtual Healthcare Conference at 3:00 p.m. ET on April 15, 2026; and will meet with investors at the Raymond James BioPharma Conference on April 14, 2026. Webcasts and replays will be available via the company’s investor relations website: https://www.globenewswire.com/Tracker?data=srv7yyuJxCBviQ_Hg_-44k7R7ZAp0TMspbRdIyrbF6AhIOda_KyxxPGOh8-k7t-LWW0d9C4rLRx0MzD_N34DK8ZhSaUS7gfD09-kRuSBYYQjTvTqEUrq7G-_xEIu8EIEmX1rz-R0XDwk6mUp1Uf6TQ==.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Black Diamond Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603021601PRIMZONEFULLFEED9664074) on March 02, 2026, and is solely responsible for the information contained therein.
Comments